| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥28.9B | ¥31.7B | -8.7% |
| Operating Income | ¥-2.7B | ¥-7.1B | +61.3% |
| Profit Before Tax | ¥3.7B | ¥-3.0B | +223.9% |
| Net Income | ¥1.9B | ¥-4.7B | +140.7% |
| ROE | 0.5% | -1.2% | - |
FY2026 Q3 consolidated results: Revenue 28.9B yen (YoY -8.7%), Operating Loss 2.7B yen (loss narrowed +61.3% from -7.1B yen), Net Income 1.9B yen (YoY +140.7%, turning from -4.7B yen loss to profit). Despite top-line contraction, the company achieved profitability recovery through non-operating items including financial income of 7.9B yen and investment-related gains. Operating level remained in deficit with operating margin of -9.5%, reflecting SG&A expenses of 24.3B yen against gross profit of 17.8B yen (gross margin 61.4%). The profit turnaround was primarily driven by financial income and investment activities rather than core operational improvements. Balance sheet remained robust with total assets of 490.0B yen, total equity of 397.9B yen, and equity ratio of 81.2%. Cash and equivalents stood at 92.0B yen, providing strong liquidity cushion. Free cash flow reached 24.5B yen, significantly boosted by investing cash inflows of 21.5B yen from investment sales.
Revenue declined 8.7% YoY to 28.9B yen, reflecting challenging demand environment or changes in product mix. Despite revenue contraction, gross profit margin remained high at 61.4% with gross profit of 17.8B yen, indicating strong pricing power or favorable cost structure in core products. However, SG&A expenses of 24.3B yen (84.0% of revenue) significantly exceeded gross profit, resulting in operating loss of 2.7B yen. R&D expenses totaled 6.7B yen, representing 23.3% of revenue, demonstrating continued investment in technology development despite operational challenges. Operating loss improved by 4.3B yen (narrowing from -7.1B yen to -2.7B yen), primarily due to better expense management rather than revenue growth. The path from operating loss to net profit involved substantial non-operating contributions: financial income of 7.9B yen exceeded financial costs of 2.6B yen, generating net financial income of 5.3B yen. Equity method investment loss was minimal at -0.1B yen. Combined with other income of 4.3B yen, profit before tax reached 3.7B yen. However, an exceptionally high effective tax rate of 48.6% resulted in tax expense of 1.8B yen, bringing net income to 1.9B yen. The significant gap between operating income and net income (6.3B yen difference) stemmed primarily from non-recurring factors including investment portfolio gains and elevated financial income. These non-operating items accounted for the profitability turnaround and represent one-time or variable revenue sources rather than sustainable operational improvements. This represents a revenue down/profit up pattern, where the profit recovery was achieved not through operational excellence but through financial engineering and investment liquidation.
[Profitability] ROE of 0.5% remains substantially below industry standards, reflecting low profitability despite balance sheet strength. Operating margin of -9.5% indicates core business remains unprofitable, contrasting sharply with industry median of 8.9%. Net profit margin of 6.6% appears favorable on surface but relies heavily on non-operating income rather than operational efficiency. The company's 3-year historical operating margins have consistently remained negative, indicating structural challenges in expense management. [Cash Quality] Cash and equivalents of 92.0B yen provide robust liquidity coverage. Short-term debt coverage remains strong given the company's low leverage position. Operating cash flow of 3.0B yen represents 1.57x coverage of net income, confirming cash-backed earnings quality. [Investment Efficiency] Asset turnover of 0.059 significantly trails industry median of 0.56, reflecting underutilization of the company's 490.0B yen asset base. Inventory turnover of 341 days vastly exceeds industry median of 112 days, indicating severe inventory management inefficiency. Working capital cycle of 208 days is substantially longer than industry median of 111 days, suggesting capital tied up in operations. Return on assets of 0.4% compares poorly to industry median of 3.4%, demonstrating weak asset productivity. [Financial Health] Equity ratio of 81.2% substantially exceeds industry median of 63.8%, indicating conservative capital structure with financial leverage of 1.23x versus industry median of 1.53x. Net debt to EBITDA is not meaningful given negative EBITDA. Current ratio calculation limited by data availability, but cash position of 92.0B yen against conservative debt levels suggests adequate short-term liquidity. Total debt remains minimal with lease liabilities of 4.0B yen representing primary obligations.
Operating cash flow of 3.0B yen increased substantially from 0.5B yen YoY (+562.2%), representing 1.57x of net income and confirming quality of earnings from a cash generation perspective. The improvement in operating cash flow was supported by reduction in trade receivables (down 42.6% YoY), which contributed positively to working capital efficiency despite ongoing operational challenges. However, inventory outflow of 1.2B yen partially offset this benefit, consistent with elevated inventory days of 341. Investing cash flow generated significant inflow of 21.5B yen, driven primarily by proceeds from investment securities sales rather than core asset disposals. CapEx remained modest at 0.1B yen, indicating limited capital investment in growth or maintenance during the period. This investment activity was non-recurring in nature and boosted free cash flow to 24.5B yen, though the sustainability of such investment gains warrants monitoring. Financing cash flow recorded outflow of 1.5B yen, reflecting modest capital structure adjustments without significant debt repayment or shareholder distributions. Cash and equivalents increased from prior levels to 92.0B yen, strengthening the company's already robust liquidity position. The cash accumulation primarily stemmed from investment liquidation rather than operational cash generation, suggesting reliance on asset monetization to support balance sheet strength while core operations remain cash-neutral.
Operating income of -2.7B yen versus profit before tax of 3.7B yen reveals non-operating net contribution of approximately 6.4B yen, representing the critical difference between operational deficit and reported profitability. This comprises financial income of 7.9B yen (including interest, dividends, and investment gains) and other income of 4.3B yen, partially offset by financial costs of 2.6B yen and equity method loss of 0.1B yen. Non-operating income of approximately 10.6B yen represents 36.6% of revenue, an unusually high proportion indicating significant dependence on non-core activities for profitability. The composition includes investment-related gains evidenced by investing cash flow of +21.5B yen and elevated financial income, suggesting portfolio realization as a major profit driver. Operating cash flow of 3.0B yen exceeds net income on an absolute basis when considering the operating loss context, indicating healthy cash conversion at the operational activity level despite accounting losses. However, the effective tax rate of 48.6% applied to pre-tax profit of 3.7B yen appears elevated and warrants examination of tax structure or deferred tax impacts. Earnings quality assessment reveals a bifurcated picture: while cash generation from operating activities demonstrates improvement, the reported net profit heavily depends on non-recurring financial and investment gains rather than sustainable operational performance, raising concerns about profit sustainability in future periods absent continued asset monetization.
Operating Profitability Sustainability: Operating loss of 2.7B yen (margin -9.5%) with SG&A expenses at 24.3B yen (84.0% of revenue) indicates structural cost base misalignment with current revenue scale. Unless revenue recovery exceeds 30% or SG&A reduction of 7-8B yen is achieved, operating profitability remains unattainable, threatening long-term viability of core business model.
Working Capital Inefficiency: Inventory turnover of 341 days (3.3x longer than industry median of 112 days) and cash conversion cycle of 208 days indicate severe capital inefficiency. With inventory of 10.4B yen representing 36% of revenue, potential inventory obsolescence risk could result in writedowns of 2-3B yen, materially impacting future earnings and consuming cash resources.
Profit Dependency on Non-Operating Items: Net income of 1.9B yen relies on 10.6B yen of non-operating income (financial income 7.9B yen plus other income 4.3B yen) against operating loss of 2.7B yen. Investment sales generated 21.5B yen investing cash inflow, representing one-time gains. Without operational turnaround, profit sustainability requires continued asset monetization, which is inherently limited by portfolio size and market conditions.
[Industry Position] (Reference - Proprietary Analysis)
CYBERDYNE's financial profile diverges significantly from manufacturing industry peers across multiple dimensions. Profitability metrics substantially underperform sector standards: ROE of 0.5% compared to industry median of 5.8%, operating margin of -9.5% versus industry median of 8.9%, and net profit margin of 6.6% nominally matching industry median of 6.5% but relying on non-operating income rather than operational efficiency. Financial health indicators show conservative positioning with equity ratio of 81.2% exceeding industry median of 63.8% and minimal leverage. However, operational efficiency metrics reveal critical weaknesses: asset turnover of 0.059 significantly trails industry median of 0.56 (90% below peer group), inventory days of 341 versus industry median of 112 (3x longer), and working capital cycle of 208 days compared to industry median of 111 days. Revenue contraction of -8.7% contrasts with industry median growth of 2.8%, placing the company in bottom quartile for top-line performance. The company's R&D intensity of 23.3% substantially exceeds typical manufacturing sector levels, suggesting technology-focused business model with extended commercialization timeline. While balance sheet strength provides financial stability cushion, operational metrics indicate the company operates at below-scale efficiency relative to established manufacturing peers, characteristic of growth-stage or specialized technology companies facing commercialization challenges rather than mature industrial operations.
(Industry: Manufacturing (N=105 companies), Comparison: FY2025 Q3, Source: Proprietary analysis)
Profitability Structure Transition Underway: The company demonstrated ability to generate net profit of 1.9B yen despite operating loss of 2.7B yen through financial income of 7.9B yen and investment gains reflected in 21.5B yen investing cash inflow. This indicates successful asset monetization capability and portfolio management, though raises questions about operational turnaround timeline and sustainability of profit without continued asset sales.
Balance Sheet Strength Provides Strategic Flexibility: Equity ratio of 81.2% and cash position of 92.0B yen against minimal debt obligations create substantial financial flexibility for strategic initiatives. The conservative capital structure positions the company to sustain operations through extended commercialization phase or fund potential M&A, partnerships, or restructuring without liquidity constraints, despite ongoing operating losses.
Operational Efficiency Improvement Critical Path: Inventory days of 341 and working capital cycle of 208 days (both approximately 3x industry medians) represent quantifiable improvement opportunities. Reducing inventory to industry-standard levels could release 7-8B yen in working capital, while SG&A optimization toward sustainable operating profitability remains the fundamental challenge requiring structural cost reduction of 25-30% or revenue growth exceeding 40% to achieve breakeven.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.